No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleonly females |
313377 |
2. Check conditionsNone |
313377 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
242 |
4. Check minimum number of eventsNone |
242 |
5. Include endpointsNone |
242 |
6. Filter based on genotype QC (FinnGen only) |
215 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Endometroid carcinoma of ovary
based on the number of shared cases.
Similar with more cases:
- Endometroid carcinoma of ovary, including Hilmo
- Malignant neoplasm of ovary
- Malignant neoplasm of ovary, including Hilmo
- malignant neoplasm of female genital organs
- malignant neoplasm of female genital organs, including Hilmo
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 215 | 215 | - |
| Unadjusted period prevalence (%) | 0.08 | 0.08 | - |
| Median age at first event (years) | 57.75 | 57.75 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 222
- Matched controls
- 2220
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8380/3-C56.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of ovary
+∞
321.5
222
*
H02AB02
ATC
dexamethasone; systemic
182.6
245.6
123
15
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
+∞
230.2
179
*
A04AA01
ATC
ondansetron; systemic, rectal
59.6
157.0
94
27
128
Kela drug reimbursment
Cancers of female genital organs
+∞
146.6
124
*
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
50.4
134.4
83
26
WX302
NOMESCO Finland
Thoracal epidural anesthesy
57.8
133.5
79
21
A03FA01
ATC
metoclopramide; systemic, rectal
17.8
109.0
149
228
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
108.5
95
*
JEA00
NOMESCO Finland
Appendectomy
22.6
89.7
74
48
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
18.4
85.3
80
66
JN4BD
NOMESCO Finland
Extensive body CT
26.0
84.6
64
34
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
71.9
65
*
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
70.7
64
*
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
25.2
68.0
51
26
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
62.5
57
*
B01AB10
ATC
tinzaparin; parenteral
9.7
55.4
82
126
JAL30
NOMESCO Finland
Omentectomy
148.8
54.7
56
5
JN4AD
NOMESCO Finland
Body CT examination
12.3
52.6
60
65
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
52.2
48
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
14.3
49.1
49
43
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
13.6
44.8
46
42
L03AA13
ATC
pegfilgrastim; parenteral
436.6
38.2
37
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
389.5
33.9
33
*
L02BG04
ATC
letrozole; oral
71.1
32.2
36
6
A04AA02
ATC
granisetron; systemic, transdermal
361.1
31.7
31
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
31.0
29
*
TPH07
NOMESCO Finland
Cathetrisation of artery
6.3
30.2
62
129
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
29.9
28
*
LCD00
NOMESCO Finland
Hysterectomy
7.9
28.8
44
67
Z51.5
ICD-10 Finland
Palliative care
10.9
28.7
33
35
Z31.5
ICD-10 Finland
Genetic counselling
10.4
28.5
34
38
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
11.2
28.3
32
33
L03AA02
ATC
filgrastim; parenteral
+∞
27.7
26
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
27.7
26
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
26.6
25
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
292.9
26.3
26
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
25.5
24
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
5.0
24.3
65
169
ZXE20
NOMESCO Finland
More than three and less than five hours
5.1
23.7
60
149
1830A
ICD-9 Finland
Malignant neoplasm of ovary and other uterine adnexa, Ovary
+∞
23.3
22
*
A04AA03
ATC
tropisetron; systemic
+∞
22.3
21
*
B01AB05
ATC
enoxaparin; parenteral
3.8
21.9
116
493
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
+∞
21.2
20
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
21.2
20
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
4.8
21.0
57
149
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
230.8
20.9
21
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
3.7
20.6
121
545
JAL00
NOMESCO Finland
Biopsy of peritoneum
76.8
19.1
21
*
115
Kela drug reimbursment
Breast cancer
+∞
19.0
18
*
130
Kela drug reimbursment
Malignant tumour
+∞
19.0
18
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
19.0
18
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
19.0
18
*
HA1AA
NOMESCO Finland
X-ray mammography
6.4
18.3
33
59
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
18.0
17
*
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
+∞
18.0
17
*
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
4.4
17.4
51
140
WX402
NOMESCO Finland
General anaesthesia
3.7
17.4
71
248
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
7.0
16.7
27
43
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.4
16.0
46
124
L02BA01
ATC
tamoxifen; oral
+∞
15.8
15
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
15.8
15
*
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
91.7
15.8
17
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
91.7
15.8
17
*
WZC00
NOMESCO Finland
Treatment plan or consultation
3.1
15.0
98
451
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
14.7
14
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
14.7
14
*
C567, ,
ICD-10 Finland
+∞
14.7
14
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
160.1
14.6
15
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
160.1
14.6
15
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
12.6
14.2
25
22
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
6.3
14.0
25
44
JAH00
NOMESCO Finland
Laparotomy
14.1
13.8
23
18
X77
ICPC
Malignant neopl genital female other
+∞
13.7
13
*
JAL31
NOMESCO Finland
Laparoscopic omentectomy
+∞
13.7
13
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
13.7
13
*
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
+∞
13.7
13
*
C56.72
ICD-10 Finland
Mucinous epithelial carcinoma of the ovary
+∞
13.7
13
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.3
13.5
66
254
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
74.2
12.7
14
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
12.6
12
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
12.6
12
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
12.6
12
*
JAH01
NOMESCO Finland
Laparoscopy
6.0
12.4
23
42
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
5.9
12.1
23
43
D39.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified
49.5
12.0
14
*
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
32.0
11.8
15
5
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
11.6
11
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
126.3
11.5
12
*
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
26.6
11.3
15
6
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
16.6
11.0
17
11
L02AB02
ATC
medroxyprogesterone; systemic
29.7
10.9
14
5
ZX120
NOMESCO Finland
Intravenous
4.8
10.8
26
60
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
+∞
10.5
10
*
N02AA05
ATC
oxycodone; systemic
2.9
10.1
58
241
D39.19
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary with unspecified histology
27.5
9.9
13
5
WW500
NOMESCO Finland
Blood transfusion
10.2
9.5
18
19
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
9.4
9
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
9.4
9
*
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
+∞
9.4
9
*
XX3DW
NOMESCO Finland
Time consuming IT work
4.6
9.4
23
54
WX306
NOMESCO Finland
Lumbar epidural anesthesy
4.3
9.3
25
63
K56.7
ICD-10 Finland
Ileus, unspecified
16.5
9.2
14
9
TPX10
NOMESCO Finland
Implantation of vascular injection port
14.8
8.8
14
10
R18
ICD-10 Finland
Ascites
14.8
8.8
14
10
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
52.1
8.7
10
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
28.8
8.6
11
*
JN3AD
NOMESCO Finland
Abdominal CT examination
3.1
8.5
39
142
ZXC40
NOMESCO Finland
Use of ultrasound
93.5
8.5
9
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
8.4
8
*
18301
ICD-8 Finland
Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary
+∞
8.4
8
*
A79
ICPC
Malignancy NOS
+∞
8.4
8
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
8.4
8
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
8.4
8
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
8.4
8
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
15.2
8.3
13
9
N80.1
ICD-10 Finland
Endometriosis of ovary
7.3
8.3
19
28
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
18.0
8.2
12
7
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
4.0
8.1
24
65
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
11.4
7.9
14
13
HAB40
NOMESCO Finland
Wedge excision of mammary gland
19.2
7.7
11
6
B01AB04
ATC
dalteparin; parenteral
4.3
7.5
20
50
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
82.7
7.5
8
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
6.7
7.4
18
29
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
9.9
7.4
14
15
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
7.3
7
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
7.3
7
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
7.3
7
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
7.3
7
*
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
+∞
7.3
7
*
8102
FHL
Second look"" surgery for a malignant tumor
+∞
7.3
7
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
7.3
7
*
N02AX02
ATC
tramadol; systemic, rectal
2.1
7.2
116
750
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
31.1
7.2
9
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.0
7.2
34
126
WF002
NOMESCO Finland
Radical radiotherapy
41.4
6.8
8
*
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
41.4
6.8
8
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
41.4
6.8
8
*
JAW96
NOMESCO Finland
Other operation on abdominal wall, peritoneum, mesentery or omentum
71.8
6.5
7
*
JFB00
NOMESCO Finland
Partial resection of small intestine
18.7
6.3
9
5
C56.74
ICD-10 Finland
Mesonephroid epithelial carcinoma of the ovary
+∞
6.3
6
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
JAQ00
NOMESCO Finland
Extensive excision of peritoneum
+∞
6.3
6
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
+∞
6.3
6
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
6.3
6
*
JFF10
NOMESCO Finland
Loop enterostomy
+∞
6.3
6
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
7.0
6.1
14
21
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.1
6.1
26
90
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
87
110
12.36
69.60
2.8
1.5
4.00
2.60
ug/l
0.76
67
84
31
47
7.50
20.14
3.0
1.9
31.29
16.20
u/ml
0.94
24
40
64
223
3.63
15.54
11.1
5.3
0.59
1.54
mmol/l
1.16
56
193
95
433
3.09
14.73
2.5
1.8
—
—
—
0
0
150
882
3.16
14.68
5.6
3.5
34.36
36.06
g/l
3.12
144
815
146
864
3.01
13.77
3.2
2.2
—
—
estimate
—
0
0
160
1013
3.07
13.02
16.4
6.1
3.74
4.11
e9/l
1.62
134
871
153
982
2.80
11.47
9.6
3.4
9.18
10.65
umol/l
2.72
145
926
14
10
14.84
8.81
1.0
1.4
—
—
—
0
0
13
16
8.55
6.43
1.0
2.4
3.85
233.83
u/ml
0.47
13
16
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
37
4.89
5.62
4.5
2.6
0.29
0.46
iu/ml
—
7
26
28
112
2.72
5.11
19.9
6.4
0.76
0.66
%
0.67
28
112
73
445
1.95
4.92
2.0
1.6
1.32
1.09
mg/l
0.47
63
352
180
1475
2.16
4.92
11.0
5.5
81.20
75.39
u/l
1.56
167
1360
28
117
2.59
4.70
19.9
6.3
95.51
93.74
%
1.96
28
117
28
118
2.57
4.62
19.2
6.2
1.20
1.33
%
0.54
28
118
40
201
2.21
4.48
2.6
2.1
4.06
5.28
umol/l
2.29
33
169
165
1888
0.51
4.32
6.9
6.9
39.59
39.50
mmol/mol
0.04
147
1768
25
104
2.58
4.23
13.2
6.0
24.14
25.23
mmol/l
0.80
25
104
46
255
2.01
3.99
15.2
4.5
103.74
104.22
mmol/l
0.29
46
255
145
1146
1.76
3.89
5.4
4.3
0.00
0.02
estimate
0.68
20
208
28
130
2.32
3.77
5.0
4.4
8.14
10.13
mmol/l
1.07
28
119
9
16
5.81
3.70
3.0
2.2
2054.82
25.27
u/ml
—
9
16
176
1957
0.51
3.64
5.3
5.5
4.85
4.79
mmol/l
0.30
163
1804
176
1957
0.51
3.64
5.4
5.6
5.84
5.93
mmol/l
0.44
160
1788
29
141
2.22
3.51
1.4
1.5
—
—
—
0
0
124
958
1.67
3.43
8.5
4.8
1.18
1.22
mmol/l
5.31
117
867
180
1982
0.51
3.41
6.1
6.4
2.74
2.75
mmol/l
0.06
163
1820
7
10
7.18
3.39
1.3
1.4
—
—
—
0
0
134
1068
1.64
3.19
8.6
5.6
1.18
1.22
mmol/l
6.32
122
928
176
1941
0.55
3.02
5.1
5.4
1.61
1.61
mmol/l
0.07
158
1783
173
1912
0.57
2.86
6.1
6.3
1.73
1.91
mu/l
1.53
158
1776
53
343
1.72
2.79
2.8
2.9
1.32
1.99
e6/l
0.44
21
170
33
186
1.91
2.72
1.8
2.1
26.88
34.60
u/l
0.81
25
149
14
56
2.60
2.58
10.1
4.2
3.64
3.80
mmol/l
0.59
14
56
29
160
1.93
2.54
2.6
2.5
222.62
233.83
u/l
0.32
29
150
47
303
1.70
2.50
2.9
3.2
4.09
5.32
e6/l
0.29
17
127
13
284
0.42
2.44
4.3
5.4
31.17
33.95
%
—
6
174
91
693
1.53
2.43
3.4
3.3
—
—
—
0
0
86
647
1.54
2.42
3.0
2.1
97.95
56.93
u/l
0.54
78
588
150
1699
0.64
2.41
4.9
4.9
14.76
14.97
pmol/l
0.51
131
1567
8
22
3.73
2.38
1.0
1.4
—
—
—
0
0
49
701
0.61
2.36
2.1
2.1
107.05
126.03
u/l
0.37
43
668
95
748
1.47
2.09
4.1
2.2
2.36
2.37
mmol/l
0.44
90
653
135
1141
1.47
2.04
5.6
4.3
0.00
0.00
estimate
-0.00
21
215
19
98
2.03
2.02
1.8
1.5
—
—
—
0
0
72
543
1.48
1.94
2.6
3.2
0.65
0.53
e6/l
0.16
43
395
9
35
2.64
1.82
1.3
1.2
—
—
—
0
0
7
23
3.11
1.81
1.4
1.3
—
—
—
0
0
14
67
2.16
1.80
10.1
3.8
1.57
1.28
mmol/l
0.39
14
67
14
68
2.13
1.74
1.5
1.7
—
—
—
0
0
131
1122
1.41
1.71
5.6
4.3
0.00
0.00
estimate
-0.00
19
206
35
232
1.60
1.68
2.0
1.7
—
—
—
0
0
8
31
2.64
1.67
1.4
1.3
—
—
—
0
0
72
901
0.70
1.66
2.4
1.9
1.35
1.31
mmol/l
0.18
61
769
56
416
1.46
1.61
1.4
1.4
—
—
—
0
0
172
1855
0.68
1.56
4.1
4.6
1.26
1.26
mmol/l
0.05
150
1680
86
1031
0.73
1.47
2.7
2.6
82.35
81.82
nmol/l
0.05
79
921
6
23
2.65
1.37
1.0
1.3
—
—
—
0
0
169
1541
1.41
1.35
35.5
17.5
14.37
13.62
%
7.79
169
1515
21
130
1.68
1.32
4.3
3.1
4.43
4.43
pmol/l
0.00
21
116
7
141
0.48
1.26
1.3
1.4
—
58.59
—
0
12
8
38
2.15
1.19
1.0
1.1
—
—
—
0
0
34
244
1.46
1.17
2.1
1.7
—
—
—
0
0
8
39
2.09
1.16
1.3
1.2
—
—
—
0
0
5
20
2.53
1.15
1.0
1.2
—
—
—
0
0
29
202
1.50
1.15
3.0
2.6
0.71
2.38
mmol/l
1.06
24
179
7
32
2.23
1.09
1.0
1.3
—
—
—
0
0
7
32
2.23
1.09
1.0
1.3
—
—
—
0
0
39
504
0.73
1.02
1.1
1.3
0.56
1.98
u/ml
—
8
123
42
323
1.37
1.00
2.0
1.7
—
—
—
0
0
7
36
1.97
0.98
1.3
1.2
—
—
—
0
0
11
184
0.58
0.98
3.8
3.2
142.09
75.88
ng/l
0.71
11
161
54
434
1.32
0.97
5.2
4.3
15.22
113.67
ng/l
2.31
46
335
89
1018
0.79
0.94
2.5
2.2
81.14
102.38
pmol/l
2.41
39
473
10
55
1.86
0.93
1.3
1.7
—
—
—
0
0
6
28
2.17
0.92
1.3
1.1
—
—
—
0
0
97
847
1.26
0.91
4.8
4.0
0.40
0.04
estimate
0.89
20
160
200
2067
0.67
0.90
40.5
21.5
4.18
4.40
e12/l
8.42
194
2008
8
44
1.85
0.87
1.5
1.6
—
—
—
0
0
6
113
0.52
0.85
1.0
1.7
—
—
—
0
0
17
114
1.53
0.82
2.7
2.4
0.66
0.62
%
0.30
17
114
17
115
1.52
0.79
2.7
2.4
1.14
1.23
%
0.28
17
115
198
1899
1.39
0.78
24.0
13.9
35.57
20.15
mg/l
6.55
181
1515
16
109
1.50
0.73
1.3
1.5
—
—
—
0
0
24
179
1.38
0.70
2.8
3.3
—
—
—
0
0
7
43
1.65
0.67
3.7
2.8
—
—
—
0
0
35
430
0.78
0.65
1.3
1.3
44.60
11.01
u/ml
—
8
160
23
173
1.37
0.65
5.0
3.9
122.17
252.97
ng/l
1.21
18
161
5
29
1.74
0.64
1.2
1.4
—
—
—
0
0
61
529
1.21
0.59
2.5
2.4
2.98
2.93
mg/l
0.06
51
444
54
464
1.22
0.57
2.9
2.2
2.47
2.46
mmol/l
0.43
48
411
6
36
1.68
0.57
1.2
1.4
—
—
—
0
0
144
1525
0.84
0.56
4.6
4.8
16.59
12.61
mm/h
1.91
130
1406
13
181
0.70
0.55
1.5
1.5
—
—
—
0
0
26
324
0.78
0.54
1.6
1.6
—
—
—
0
0
7
45
1.57
0.49
1.4
1.6
—
—
—
0
0
5
31
1.63
0.43
1.2
1.0
—
—
—
0
0
20
159
1.28
0.42
3.3
2.3
56.75
67.77
ml/min/173m2
0.77
12
65
56
626
0.86
0.41
5.3
4.4
0.05
0.00
estimate
0.48
19
202
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
0
18
0.00
0.40
0.0
1.7
—
28.00
—
0
5
0
19
0.00
0.39
0.0
1.4
—
0.95
—
0
8
0
19
0.00
0.39
0.0
1.4
—
1.23
—
0
8
0
19
0.00
0.39
0.0
1.4
—
0.95
—
0
8
5
78
0.63
0.36
1.0
1.3
—
31.56
—
0
5
70
763
0.88
0.36
4.2
3.8
9.72
4.97
mg/mmol
0.72
39
430
64
586
1.13
0.32
4.3
3.5
0.25
0.00
estimate
0.77
20
174
104
1097
0.90
0.29
2.8
2.8
—
—
—
0
0
86
809
1.10
0.26
4.4
3.9
29.58
64.83
ng/l
0.40
58
586
52
477
1.12
0.25
2.1
2.1
315.18
325.23
umol/l
0.37
45
404
10
126
0.78
0.25
1.0
1.8
—
—
—
0
0
57
527
1.11
0.24
5.0
4.4
1.02
1.02
kg/l
0.35
37
336
5
40
1.26
0.22
1.2
1.2
1.70
1.68
g/l
—
5
40
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
1.04
—
0
5
0
11
0.00
0.21
0.0
1.3
—
105.97
—
0
11
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
5
43
1.17
0.21
1.2
1.3
0.72
0.90
g/l
—
5
43
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
35
384
0.89
0.20
1.5
1.7
1254.44
1190.58
nmol/l
0.15
27
285
94
983
0.92
0.20
3.4
3.0
108.34
89.96
ug/l
0.55
89
913
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
7
59
1.19
0.18
1.0
1.1
—
—
—
0
0
5
68
0.73
0.17
1.8
1.4
—
—
—
0
0
122
1255
0.94
0.15
4.7
3.0
47.35
40.23
u/l
0.58
110
1156
25
274
0.90
0.14
11.0
6.9
—
—
—
0
0
66
691
0.94
0.14
1.9
1.7
24.82
21.76
nmol/l
0.74
57
585
6
58
1.04
0.08
1.8
1.3
128.50
181.08
ug/l
—
6
53
5
60
0.83
0.08
1.0
1.3
—
77.72
—
0
6
5
64
0.78
0.08
1.8
1.4
—
—
—
0
0
187
1855
1.05
0.06
25.0
13.4
75.17
76.40
ml/min/173m2
0.35
176
1701
15
162
0.92
0.06
1.1
1.2
177.84
128.17
u/ml
—
7
68
43
445
0.96
0.06
1.7
1.8
1560.20
481.99
pmol/l
0.44
30
355
10
107
0.93
0.02
1.0
1.1
—
—
—
0
0
69
692
1.00
0.00
3.5
2.8
2278.27
1027.01
ng/l
0.68
62
583
45
455
0.99
0.00
1.3
1.3
14.55
40.21
iu/ml
3.36
11
146
11
105
1.05
0.00
1.1
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
34.68
—
0
5
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
9.86
—
0
7
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
6
69
0.87
-0.00
1.0
1.2
—
—
—
0
0
6
69
0.87
-0.00
1.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
10.01
—
0
7
0
7
0.00
-0.00
0.0
1.0
—
2467.71
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
6
69
0.87
-0.00
1.0
1.2
—
—
—
0
0
7
75
0.93
-0.00
1.7
1.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
58
0.86
-0.00
1.2
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.0
—
17.53
—
0
6
0
6
0.00
-0.00
0.0
3.3
—
544.50
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_OVARY_ENDOMETROID – Endometroid carcinoma of ovary
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).